Skip to main content
Erschienen in: International Journal of Hematology 5/2011

01.05.2011 | Original Article

Quality assessment of umbilical cord blood units at the time of transplantation

verfasst von: Yoshinori Kudo, Masayoshi Minegishi, Osamu Seki, Hiroyuki Takahashi, Akira Suzuki, Ayuko Narita, Yuko Sato, Machiko Abe, Natsuko Ishioka, Hideo Harigae, Shigeru Tsuchiya

Erschienen in: International Journal of Hematology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Total nucleated cell (TNC) count, CD34+ cell count, colony-forming unit-granulocyte–macrophage (CFU-GM) content, and cell viability impact the outcome of umbilical cord blood (UCB) transplantation. Assessments of unit quality have usually been provided by cord blood banks (CBBs), but it is unclear whether pre-freezing tests or pre-transplant release tests performed by CBBs are reproducible. The aim of this study was to compare the UCB characteristics analyzed at the site of infusion of the UCB with those provided by CBBs. Samples were taken from 54 UCB units for assessment of post-thaw characteristics. TNC counts and CD34+ cell contents measured at our hospital before infusion showed good correlations with values assessed in pre-freezing tests (r = 0.900 and 0.943, respectively) and pre-transplant release tests (r = 0.829 and 0.930, respectively). Our data reveal that the TNC counts and CD34+ cell contents determined by pre-freezing and pre-transplant release tests, which are the most important UCB unit selection criteria, accurately reflected the quality of infused UCB units. However, CFU-GM content was poorly correlated (r = 0.560 and 0.606). Correlation of post-thaw cell viabilities measured before infusion and during the pre-transplant release tests was also poor (r = 0.308). We suggest that the TNC count and CD34+ cell content estimated before cryopreservation and in pre-transplant release tests provided by CBBs are reproducible and can assist the transplant physicians in selection of appropriate UCB units.
Literatur
1.
Zurück zum Zitat Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8.PubMed Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8.PubMed
2.
Zurück zum Zitat Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.CrossRefPubMed Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.CrossRefPubMed
3.
Zurück zum Zitat Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.CrossRefPubMed Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.CrossRefPubMed
4.
Zurück zum Zitat Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813–20.CrossRefPubMed Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813–20.CrossRefPubMed
5.
Zurück zum Zitat Eapen M, Rocha V, Sanz G, et al. Effects of graft source on unrelated donor haematopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analysis. Lancet Oncol. 2010;11:653–60.CrossRefPubMedPubMedCentral Eapen M, Rocha V, Sanz G, et al. Effects of graft source on unrelated donor haematopoietic stem-cell transplantation in adults with acute leukemia: a retrospective analysis. Lancet Oncol. 2010;11:653–60.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Picardi A, Arcese W. Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. Transfus Apheresis Sci. 2010;42:289–97.CrossRef Picardi A, Arcese W. Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. Transfus Apheresis Sci. 2010;42:289–97.CrossRef
7.
Zurück zum Zitat McCullough J, McKenna D, Kadidlo D, et al. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion. 2005;45:832–41.CrossRefPubMed McCullough J, McKenna D, Kadidlo D, et al. Issues in the quality of umbilical cord blood stem cells for transplantation. Transfusion. 2005;45:832–41.CrossRefPubMed
8.
Zurück zum Zitat Wagner E, Duval M, Dalle J-H, et al. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion. 2006;46:1190–8.CrossRefPubMed Wagner E, Duval M, Dalle J-H, et al. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion. 2006;46:1190–8.CrossRefPubMed
9.
Zurück zum Zitat Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry. 1998;34:61–70.CrossRefPubMed Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry. 1998;34:61–70.CrossRefPubMed
10.
Zurück zum Zitat Itoh T, Minegishi M, Fushimi J, et al. A simple controlled-rate freezing method without a rate-controlled programmed freezer provides optimal conditions for both large scale and small scale of umbilical cord blood cells. Transfusion. 2003;43:1303–8.CrossRefPubMed Itoh T, Minegishi M, Fushimi J, et al. A simple controlled-rate freezing method without a rate-controlled programmed freezer provides optimal conditions for both large scale and small scale of umbilical cord blood cells. Transfusion. 2003;43:1303–8.CrossRefPubMed
11.
Zurück zum Zitat Querol S, Gomez SG, Pagliuca A, et al. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant. 2010;45:970–8.CrossRefPubMed Querol S, Gomez SG, Pagliuca A, et al. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transplant. 2010;45:970–8.CrossRefPubMed
12.
Zurück zum Zitat Stevens CE, Gladstone J, Taylor PE, et al. Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood. 2002;100:2662–4.CrossRefPubMed Stevens CE, Gladstone J, Taylor PE, et al. Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood. 2002;100:2662–4.CrossRefPubMed
13.
Zurück zum Zitat Nagamura-Inoue T, Shioya M, Sugo M, et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion. 2003;43:1285–94.CrossRefPubMed Nagamura-Inoue T, Shioya M, Sugo M, et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion. 2003;43:1285–94.CrossRefPubMed
14.
Zurück zum Zitat Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE. Damage and protection of UC blood cells during cryopreservation. Cytotherapy. 2001;3:377–86.CrossRefPubMed Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE. Damage and protection of UC blood cells during cryopreservation. Cytotherapy. 2001;3:377–86.CrossRefPubMed
15.
Zurück zum Zitat Allan DS, Keeney M, Howson-Jan K, et al. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967–72.CrossRefPubMed Allan DS, Keeney M, Howson-Jan K, et al. Number of viable CD34+ cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967–72.CrossRefPubMed
16.
Zurück zum Zitat Gratama JW, Kraan J, Keeney M, et al. Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy. 2003;5:55–65.CrossRefPubMed Gratama JW, Kraan J, Keeney M, et al. Validation of the single-platform ISHAGE method for CD34+ hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy. 2003;5:55–65.CrossRefPubMed
17.
Zurück zum Zitat Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant. 1996;18:725–31.PubMed Donaldson C, Armitage WJ, Denning-Kendall PA, Nicol AJ, Bradley BA, Hows JM. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant. 1996;18:725–31.PubMed
18.
Zurück zum Zitat Kudo Y, Minegishi M, Itoh T, et al. Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved with a simple controlled-rate freezing method. Tohoku J Exp Med. 2005;205:37–43.CrossRefPubMed Kudo Y, Minegishi M, Itoh T, et al. Evaluation of hematological reconstitution potential of autologous peripheral blood progenitor cells cryopreserved with a simple controlled-rate freezing method. Tohoku J Exp Med. 2005;205:37–43.CrossRefPubMed
19.
Zurück zum Zitat Iori AP, Cerretti R, De Felice M, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant. 2004;33:1097–105.CrossRefPubMed Iori AP, Cerretti R, De Felice M, et al. Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation. Bone Marrow Transplant. 2004;33:1097–105.CrossRefPubMed
20.
Zurück zum Zitat Minegishi M, Itoh T, Fukawa N, et al. Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer. Int J Hematol. 2007;85:78–84.CrossRefPubMed Minegishi M, Itoh T, Fukawa N, et al. Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer. Int J Hematol. 2007;85:78–84.CrossRefPubMed
Metadaten
Titel
Quality assessment of umbilical cord blood units at the time of transplantation
verfasst von
Yoshinori Kudo
Masayoshi Minegishi
Osamu Seki
Hiroyuki Takahashi
Akira Suzuki
Ayuko Narita
Yuko Sato
Machiko Abe
Natsuko Ishioka
Hideo Harigae
Shigeru Tsuchiya
Publikationsdatum
01.05.2011
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 5/2011
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0830-y

Weitere Artikel der Ausgabe 5/2011

International Journal of Hematology 5/2011 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.